Ajax loader

Search results for: anaplastic-lymphoma-kinase

Anaplastic Lymphoma Kinase
SS2976005
RM
Greg Williams / Science Source
Anaplastic Lymphoma Kinase
Anaplastic Lymphoma Kinase
SS2976004
RM
Greg Williams / Science Source
Anaplastic Lymphoma Kinase
Anaplastic Lymphoma Kinase
SS2976003
RM
Greg Williams / Science Source
Anaplastic Lymphoma Kinase
Anaplastic Lymphoma Kinase
SS2976000
RM
Greg Williams / Science Source
Anaplastic Lymphoma Kinase
Anaplastic Lymphoma Kinase model
SS21022729
RM
Greg Williams / Science Source
Anaplastic Lymphoma Kinase model
Anaplastic Lymphoma Kinase model
SS21022728
RM
Greg Williams / Science Source
Anaplastic Lymphoma Kinase model
Anaplastic Lymphoma Kinase model
SS21022727
RM
Greg Williams / Science Source
Anaplastic Lymphoma Kinase model
Anaplastic Lymphoma Kinase model
SS21022726
RM
Greg Williams / Science Source
Anaplastic Lymphoma Kinase model
Anaplastic Lymphoma Kinase with Crizotinib
SS2966110
RM
Spencer Sutton / Science Source
Anaplastic Lymphoma Kinase with Crizotinib
Anaplastic Lymphoma Kinase with Crizotinib
SS2966108
RM
Spencer Sutton / Science Source
Anaplastic Lymphoma Kinase with Crizotinib
Anaplastic Lymphoma Kinase with Crizotinib
SS2966107
RM
Spencer Sutton / Science Source
Anaplastic Lymphoma Kinase with Crizotinib
Anaplastic Lymphoma Kinase with Crizotinib
SS2966106
RM
Spencer Sutton / Science Source
Anaplastic Lymphoma Kinase with Crizotinib
3d Illustration of Anaplastic Lymphoma Kinase with Crizontinib.
SS2966105
RM
Spencer Sutton / Science Source
3d Illustration of Anaplastic Lymphoma Kinase with Crizontinib.
Crizotinib, cancer drug
SS21022715
RM
Greg Williams / Science Source
Crizotinib, cancer drug
Anaplastic Lymphoma Kinase with Crizotinib
SS2966109
RM
Spencer Sutton / Science Source
Anaplastic Lymphoma Kinase with Crizotinib
Brain Cancer (treated), MRI
SS21965603
RM
Steven Needell / Science Source
Brain Cancer (treated), MRI
Brain Cancer (treated), MRI
SS21965562
RM
Steven Needell / Science Source
Brain Cancer (treated), MRI
Brain Cancer (treated), MRI
SS21965561
RM
Steven Needell / Science Source
Brain Cancer (treated), MRI
Brain Cancer (treated), MRI
SS21965560
RM
Steven Needell / Science Source
Brain Cancer (treated), MRI
Brain Cancer (treated), MRI
SS21965559
RM
Steven Needell / Science Source
Brain Cancer (treated), MRI
Brain Cancer, MRI
SS21965538
RM
Steven Needell / Science Source
Brain Cancer, MRI
Brain Cancer, MRI
SS21965537
RM
Steven Needell / Science Source
Brain Cancer, MRI
Brain Cancer, MRI
SS21965486
RM
Steven Needell / Science Source
Brain Cancer, MRI
Brain Cancer, MRI
SS21965485
RM
Steven Needell / Science Source
Brain Cancer, MRI
Brain Cancer, MRI
SS21965484
RM
Steven Needell / Science Source
Brain Cancer, MRI
Brain Cancer, MRI
SS21965482
RM
Steven Needell / Science Source
Brain Cancer, MRI
Brain Cancer, MRI
SS21965483
RM
Steven Needell / Science Source
Brain Cancer, MRI
Entrectinib cancer drug molecule, illustration
SS146935
RF
MOLEKUUL / Science Source
Entrectinib cancer drug molecule, illustration
Entrectinib cancer drug molecule, illustration
SS146884
RF
MOLEKUUL / Science Source
Entrectinib cancer drug molecule, illustration
Entrectinib cancer drug molecule, illustration
SS146866
RF
MOLEKUUL / Science Source
Entrectinib cancer drug molecule, illustration
Entrectinib cancer drug molecule, illustration
SS146735
RF
MOLEKUUL / Science Source
Entrectinib cancer drug molecule, illustration
Entrectinib cancer drug molecule, illustration
SS143887
RF
MOLEKUUL / Science Source
Entrectinib cancer drug molecule, illustration
Entrectinib cancer drug molecule, illustration
SS143825
RF
MOLEKUUL / Science Source
Entrectinib cancer drug molecule, illustration
Entrectinib cancer drug molecule, illustration
SS143813
RF
MOLEKUUL / Science Source
Entrectinib cancer drug molecule, illustration
Entrectinib cancer drug molecule, illustration
SS143749
RF
MOLEKUUL / Science Source
Entrectinib cancer drug molecule, illustration
Lorlatinib cancer drug molecule, illustration
SS22546971
RF
MOLEKUUL / Science Source
Lorlatinib cancer drug molecule, illustration
Lorlatinib cancer drug molecule, illustration
SS22546913
RF
MOLEKUUL / Science Source
Lorlatinib cancer drug molecule, illustration
Lorlatinib cancer drug molecule, illustration
SS22546831
RF
MOLEKUUL / Science Source
Lorlatinib cancer drug molecule, illustration
Lorlatinib cancer drug molecule, illustration
SS22546757
RF
MOLEKUUL / Science Source
Lorlatinib cancer drug molecule, illustration
Gilteritinib cancer drug molecule, illustration
SS22546700
RF
MOLEKUUL / Science Source
Gilteritinib cancer drug molecule, illustration
Gilteritinib cancer drug molecule, illustration
SS22546635
RF
MOLEKUUL / Science Source
Gilteritinib cancer drug molecule, illustration
Crizotinib anti-cancer drug molecule, illustration
SS22546442
RF
MOLEKUUL / Science Source
Crizotinib anti-cancer drug molecule, illustration
Crizotinib anti-cancer drug molecule, illustration
SS22546404
RF
MOLEKUUL / Science Source
Crizotinib anti-cancer drug molecule, illustration
Brigatinib cancer drug molecule, illustration
SS22546108
RF
MOLEKUUL / Science Source
Brigatinib cancer drug molecule, illustration
Brigatinib cancer drug molecule, illustration
SS22546038
RF
MOLEKUUL / Science Source
Brigatinib cancer drug molecule, illustration
Brigatinib cancer drug molecule, illustration
SS22545951
RF
MOLEKUUL / Science Source
Brigatinib cancer drug molecule, illustration
Brigatinib cancer drug molecule, illustration
SS22545913
RF
MOLEKUUL / Science Source
Brigatinib cancer drug molecule, illustration
Alectinib cancer drug molecule, illustration
SS22545825
RF
MOLEKUUL / Science Source
Alectinib cancer drug molecule, illustration
Alectinib cancer drug molecule, illustration
SS22545765
RF
MOLEKUUL / Science Source
Alectinib cancer drug molecule, illustration
Alectinib cancer drug molecule, illustration
SS22545683
RF
MOLEKUUL / Science Source
Alectinib cancer drug molecule, illustration
Alectinib cancer drug molecule, illustration
SS22545618
RF
MOLEKUUL / Science Source
Alectinib cancer drug molecule, illustration
Lorlatinib cancer drug molecule
SS21410206
RF
MOLEKUUL / Science Source
Lorlatinib cancer drug molecule
Gilteritinib cancer drug molecule, illustration
SS22546549
RF
MOLEKUUL / Science Source
Gilteritinib cancer drug molecule, illustration
Gilteritinib cancer drug molecule, illustration
SS22546474
RF
MOLEKUUL / Science Source
Gilteritinib cancer drug molecule, illustration
Crizotinib anti-cancer drug molecule, illustration
SS22546271
RF
MOLEKUUL / Science Source
Crizotinib anti-cancer drug molecule, illustration
Crizotinib anti-cancer drug molecule, illustration
SS22546217
RF
MOLEKUUL / Science Source
Crizotinib anti-cancer drug molecule, illustration
Crizotinib anti-cancer drug molecule
SS21253513
RF
MOLEKUUL / Science Source
Crizotinib anti-cancer drug molecule
Lorlatinib cancer drug molecule
SS21410207
RF
MOLEKUUL / Science Source
Lorlatinib cancer drug molecule
Lorlatinib cancer drug molecule
SS21410205
RF
MOLEKUUL / Science Source
Lorlatinib cancer drug molecule
Lorlatinib cancer drug molecule
SS21410204
RF
MOLEKUUL / Science Source
Lorlatinib cancer drug molecule
Lorlatinib cancer drug molecule
SS21410203
RF
MOLEKUUL / Science Source
Lorlatinib cancer drug molecule
Gilteritinib cancer drug molecule
SS21007284
RF
MOLEKUUL / Science Source
Gilteritinib cancer drug molecule
Gilteritinib cancer drug molecule
SS21007281
RF
MOLEKUUL / Science Source
Gilteritinib cancer drug molecule
Gilteritinib cancer drug molecule
SS21007274
RF
MOLEKUUL / Science Source
Gilteritinib cancer drug molecule
Gilteritinib cancer drug molecule
SS21007273
RF
MOLEKUUL / Science Source
Gilteritinib cancer drug molecule
Gilteritinib cancer drug molecule
SS21007272
RF
MOLEKUUL / Science Source
Gilteritinib cancer drug molecule
Crizotinib anti-cancer drug molecule
SS21189356
RF
MOLEKUUL / Science Source
Crizotinib anti-cancer drug molecule
Active Lightbox:
Open Lightboxes
Sort by
Display
Items per page
Page
of 1